Articles

Although oxaliplatin has extended the survival time of patients with colorectal cancer, the drug can also mean debilitating neurological side effects for those receiving treatments. These side effects often begin with a “pins and needles” sensation in the fingers and toes. Over time, a patient’s ability to walk or even dress independently is eventually compromised.

When battling non–small cell lung cancer (NSCLC), combination drug therapy may be required, according to the study, “STAT3 is Activated by JAK2 Independent of Key Oncogenic Driver Mutation in Non-Small Cell Lung Carcinoma.” The research, by the Translational Genomics Research Institute (TGen) and Van Andel Research Institute (VARI), was published online February 2, 2012, by the Public Library of Science ONE.

Breast cancer cell proliferation did not decline with the use of soy isoflavone supplements in a randomized clinical trial, according to a study published in Cancer Prevention Research, a journal of the American Association for Cancer Research.

These study results are compatible with the findings of previous studies designed to test dietary supplements and their cancer prevention benefits, said lead researcher Seema A. Khan, MD, professor of surgery at the Robert H. Lurie Comprehensive Cancer Center of Northwestern University.

Five different studies have successfully established the effectiveness of a blood test used for discovering and evaluating circulating tumor cells (CTCs), according to scientists from The Scripps Research Institute, Scripps Health, and other collaborating cancer physicians. The findings, published February 3, 2012, in the journal Physical Biology, show the highly sensitive blood analysis provides information that may soon be compared to the information gleaned from some types of surgical biopsies.

Research shows medication prescribing errors can be lowered by as much as 66% when electronic prescribing technology is used in hospitals.

The key to enhancing treatment for particular types of aggressive breast cancer may be the body’s control mechanisms for delivering zinc to cells.

Zinc plays a vital part in human health. However, too much or too little zinc can lead to cell death. In fact, mounting evidence associates zinc with a number of diseases, including cancer.

Monroe Township, NJ and Boston, MA, January 24, 2012 — A formal alliance known as The Lynx Group™ has been established between 4 privately owned medical communication companies each with a unique niche and expertise in the healthcare industry: Engage Healthcare Communications, Green Hill Healthcare Communications, Core Principle Solutions, and Center of Excellence Media.  

Monroe Township, NJ and Boston, MA, January 24, 2012 — A formal alliance known as The Lynx Group™ has been established between 4 privately owned medical communication companies each with a unique niche and expertise in the healthcare industry: Engage Healthcare Communications, Green Hill Healthcare Communications, Core Principle Solutions, and Center of Excellence Media.  
 

Previously, between 15% and 30% of patients treated with BRAF inhibitors developed cutaneous squamous cell carcinoma, which had to be removed surgically. Now, scientists have determined how to prevent these new cancers from occurring when patients with malignant melanoma are treated with BRAF inhibitors.

The study by researchers at The Institute of Cancer Research (ICR) was published recently in the New England Journal of Medicine.